GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
Obesity Facts · 31.07.2025 · 19 (1) · 93-108
DOI: 10.1159/000547055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Facts, online erschienen am 31.07.2025. Verfasst von Ozlem Celik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Acibadem University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Obesity, Glucagon-Like Peptide-1 Receptor Agonists, Reproduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Polycystic ovary syndrome (PCOS) is a multifaceted hormonal disorder that impacts both metabolic functions and reproductive health in women. PCOS pathophysiology is characterized by insulin resistance and chronic inflammation, which contribute to disrupted gonadotropin secretion, elevated androgen levels, and irregular ovulation. There is a bidirectional relationship between obesity and PCOS. Obesity contributes to the pathophysiology of PCOS, particularly by exacerbating insulin resistance – a core feature of the condition. Insulin resistance can lead to further weight gain and hinder successful weight loss. Summary: According to the latest international guidelines, improving insulin sensitivity and promoting weight loss are key strategies in the effective management of PCOS. GLP-1 receptor analogs (GLP-1 RAs) are a group of agents that are used in type 2 diabetes mellitus to regulate blood glucose levels, in addition to being indicated for weight loss in obesity. Thus, GLP-1 RAs may play a role in the management of PCOS, both due to weight loss effect and through pleiotropic effects like ameliorating insulin resistance, decreasing inflammation, and modulation of adiposity. Key Messages: In light of these effects, this review aimed to perform a systematic search and narrative synthesis on the impact of GLP-1 receptor agonists (GLP-1 RAs) on the metabolic and reproductive outcomes in PCOS, with the goal of elucidating the mechanistic link between the action of GLP-1 RAs and the underlying pathophysiology of the condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Acibadem University, Istanbul, Turkey.
- Koç University, Section of Endocrinology and Metabolism, Istanbul, Turkey, dyazici@ku.edu.tr.
- Vall Hebron University Hospital, Section of Endocrinology and Nutrition, Barcelona, Spain.
- Internal Medicine and Endocrinology at the Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- Department of Medical Sciences, Serbian Academy of Sciences and Arts, Belgrade, Serbia.
- Istanbul Cerrahpaşa University, Section of Endocrinology and Metabolism, Istanbul, Turkey.
Zitieren
APA
Celik, O., Yazici, D., Ciudin, A., Macut, D., Micic, D., Yumuk, V., & Yildiz, B. O. (2025). GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity. Obesity Facts, 19(1), 93-108. https://doi.org/10.1159/000547055
Vancouver
Celik O, Yazici D, Ciudin A, Macut D, Micic D, Yumuk V, et al. GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity. Obesity Facts. 2025;19(1):93-108. doi:10.1159/000547055
BibTeX
@article{Celik2025,
author = {Celik, Ozlem and Yazici, Dilek and Ciudin, Andreea and Macut, Djuro and Micic, Dragan and Yumuk, Volkan and Yildiz, Bulent Okan},
title = {GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity},
journal = {Obesity Facts},
year = {2025},
volume = {19},
number = {1},
pages = {93--108},
doi = {10.1159/000547055}
}
EUVIMED